USBC, Inc. (USBC)
NYSEAMERICAN: USBC · Real-Time Price · USD
0.5080
+0.0730 (16.78%)
At close: May 11, 2026, 4:00 PM EDT
0.5900
+0.0820 (16.14%)
After-hours: May 11, 2026, 8:00 PM EDT
USBC, Inc. Earnings Call Transcripts
Fiscal Year 2025
-
Shareholders approved all four proposals, including a major increase in authorized shares, a private placement with change of control, and an expanded equity incentive plan. The meeting achieved quorum and all votes will be reported in a Form 8-K.
-
Q1 FY2025 saw a net loss of $4.67M, heavily impacted by non-cash GAAP derivative expenses, but cash burn and R&D costs declined significantly. The new KTL licensing program aims to drive near-term revenue and offset capital challenges amid NYSE delisting proceedings.
Fiscal Year 2024
-
Q3 2024 saw key milestones in device development, clinical validation, and IP expansion, with a net loss of $4.1M and improved EPS. Cash position was bolstered by a $3.445M public offering, funding operations into late 2024.